415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis

BACKGROUND: Isavuconazole (ISA) is a novel triazole antifungal approved for treating invasive aspergillosis and mucormycosis. While ISA is increasingly used for prophylaxis in hematologic malignancy patients when other azoles are contraindicated, there are currently limited data on breakthrough inva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: DeVoe, Catherine, Fung, Monica, Schwartz, Brian, Doernberg, Sarah B, Lo, Mimi, Graff, Larissa, Tan, Marisela, Logan, Aaron, Babik, Jennifer, Chin-Hong, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253539/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.426
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados